RxDoctor Payments Data

Daniel le

Nurse Practitioner · Garden Grove, CANPI 1295244325

Payments from drug & device makers

$6,477in general payments, 2019–2025

Across 240 payments — averaging $26.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$2K
  • Lilly USA, LLC$1K
  • Abbott$593
  • Novo Nordisk$580
  • Dexcom, Inc.$573
  • Boehringer Ingelheim$545
  • plus $886 from 12 others

What the payments were for

  • Speaking & faculty fees$1,50023%
  • Food & beverage$4,95376%
  • Education$230%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,477 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide246$291,510
TrulicityDulaglutide201$281,609
JardianceEmpagliflozin139$194,562
FarxigaDapagliflozin Propanediol143$151,202
TradjentaLinagliptin130$141,217
Tresiba Flextouch U-200Insulin Degludec61$107,807
JanuviaSitagliptin Phosphate64$82,312
MounjaroTirzepatide59$66,985
Humalog Kwikpen U-200Insulin Lispro15$58,690
Fiasp FlextouchInsulin Aspart (Niacinamide)43$34,704
JanumetSitagliptin Phos/Metformin Hcl21$28,399
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog66$26,016
DapagliflozinDapagliflozin Propanediol28$24,440
Humalog Kwikpen U-100Insulin Lispro93$21,243
Nano 2nd Gen Pen NeedlePen Needle, Diabetic175$20,113

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Baqsimi, Humalog, Humalog Mix 75-25$1,461$367,779312 claims
Boehringer IngelheimJardiance, Tradjenta, Synjardy$545$350,807283 claims
Novo NordiskOzempic, Novolog$580$293,109257 claims
AstraZenecaFarxiga$347$151,202143 claims
Sanofi-aventis U.S. LLCLantus$67$3,82026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Garden Grove

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →